191 related articles for article (PubMed ID: 14991403)
21. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H; Takahashi H; Nakajima T; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Dec; 132(12):817-23. PubMed ID: 16807756
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
23. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
24. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract][Full Text] [Related]
25. High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.
Miskad UA; Semba S; Kato H; Matsukawa Y; Kodama Y; Mizuuchi E; Maeda N; Yanagihara K; Yokozaki H
Virchows Arch; 2007 Mar; 450(3):303-10. PubMed ID: 17235563
[TBL] [Abstract][Full Text] [Related]
26. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
[TBL] [Abstract][Full Text] [Related]
27. Intestinal trefoil factor: a marker of poor prognosis in gastric carcinoma.
Yamachika T; Werther JL; Bodian C; Babyatsky M; Tatematsu M; Yamamura Y; Chen A; Itzkowitz S
Clin Cancer Res; 2002 May; 8(5):1092-9. PubMed ID: 12006524
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.
Galizia G; Lieto E; Orditura M; Castellano P; Mura AL; Imperatore V; Pinto M; Zamboli A; De Vita F; Ferraraccio F
World J Surg; 2007 Jul; 31(7):1458-68. PubMed ID: 17516110
[TBL] [Abstract][Full Text] [Related]
29. High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions.
Ichinoe M; Mikami T; Yoshida T; Igawa I; Tsuruta T; Nakada N; Anzai N; Suzuki Y; Endou H; Okayasu I
Pathol Int; 2011 May; 61(5):281-9. PubMed ID: 21501294
[TBL] [Abstract][Full Text] [Related]
30. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
31. COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas.
Nie XC; Wang JP; Zhu W; Xu XY; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Hum Pathol; 2013 Jan; 44(1):77-86. PubMed ID: 22939955
[TBL] [Abstract][Full Text] [Related]
32. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.
Hashimoto T; Kusakabe T; Sugino T; Fukuda T; Watanabe K; Sato Y; Nashimoto A; Honma K; Kimura H; Fujii H; Suzuki T
Pathobiology; 2004; 71(5):267-73. PubMed ID: 15459486
[TBL] [Abstract][Full Text] [Related]
33. Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance.
del Casar JM; Corte MD; Alvarez A; García I; Bongera M; González LO; García-Muñiz JL; Allende MT; Astudillo A; Vizoso FJ
J Cancer Res Clin Oncol; 2008 Feb; 134(2):153-61. PubMed ID: 17628829
[TBL] [Abstract][Full Text] [Related]
34. [The correlation of TGF-alpha, EGFR in precancerous lesions and carcinoma of stomach with PCNA expression].
Luan F; Wang M; You W
Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):31-4. PubMed ID: 10072847
[TBL] [Abstract][Full Text] [Related]
35. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A
Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression.
Shin E; Park DJ; Kim HH; Won NH; Choe G; Lee HS
J Cancer Res Clin Oncol; 2013 Apr; 139(4):709-18. PubMed ID: 23358721
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
38. High expression of Wls is associated with lymph node metastasis and advanced TNM stage in gastric carcinomas.
Zhang W; Tao H; Chen X; Sugimura H; Wang J; Zhou P
Pathol Int; 2017 Mar; 67(3):141-146. PubMed ID: 28110490
[TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
40. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
Fujimoto D; Goi T; Hirono Y
Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
